BIO|STREAM.ICM Obesity, Submodule of the BIO|STREAM.ICM Registry
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Biotronik SE & Co. KG
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- R-wave amplitude
Study Overview
Brief Summary
The aim of the submodule study is to assess whether a high BMI may influence the sensing performance and the sECG quality of the BIOMONITOR.
Detailed Description
This submodule of the BIO|STREAM.ICM registry specifically investigates the performance of the BIOMONITOR in a subset of obese patients with a BMI >30 kg/m2 in order to exclude any concerns regarding impaired ICM sensing performance. These concerns are founded in the increased distance between heart and device electrodes due to fat layers that may attenuate signal detection and therefore sensing performances of the ICM.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient is already enrolled in the BIO|STREAM.ICM registry
- •Patient BMI > 30
Exclusion Criteria
- •Patient clinically indicated for or already implanted with another cardiac active device
Outcomes
Primary Outcomes
R-wave amplitude
Time Frame: 3 month
R-wave amplitude at 3-month Home Monitoring observation in patients with a BMI \> 30
Secondary Outcomes
- Amount of 'noise burden'(3 month)
- P-wave visibility(1 month and 3 month)
